A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia

Revle D Bangor-Jones, Gary K Dowse, Carolien M Giele, Paul G van Buynder, Meredith M Hodge and Mary M Whitty
Med J Aust 2009; 191 (7): 398-401.


Objective: To describe a prolonged outbreak of mumps in the Kimberley region of Western Australia in 2007–2008.

Design: Descriptive analysis of all mumps cases notified to the WA Notifiable Infectious Diseases Database for the period 1 July 2007 to 30 June 2008.

Main outcome measures: Notified cases of mumps by patients’ place of residence, age, Indigenous or non-Indigenous ethnicity, vaccination status and method of diagnosis.

Results: 84% (153/183) of mumps notifications in WA over the study period occurred in the Kimberley region or were directly linked to Kimberley cases. Median age of patients was 18 years (range, 2–63 years), and 54% of patients were aged less than 20 years. Almost all (92%) were Australian Aboriginal people; 67% (102/153) had received at least one dose of mumps vaccine, and 52% had received two doses. The highest notification rate (1816 cases per 100 000 population) was in the Aboriginal 15–19-years age group, and 92% of these patients had received at least one dose of mumps vaccine. Almost all outbreak cases (94%) were laboratory confirmed. Genotyping was performed on 20 mumps virus isolates: all were genotype J.

Conclusion: A prolonged outbreak of mumps occurred in a well defined, highly vaccinated, predominantly young Aboriginal population in the remote Kimberley region of WA. This outbreak raises questions about the effectiveness and scheduling of the current vaccine (which is genotype A-derived), especially for Aboriginal people. Surveillance of circulating mumps virus genotypes and neutralisation studies will help in evaluating the protection provided by the current vaccine against genotypically different strains.

  • Revle D Bangor-Jones1
  • Gary K Dowse1
  • Carolien M Giele1
  • Paul G van Buynder1
  • Meredith M Hodge2
  • Mary M Whitty3

  • 1 Communicable Disease Control Directorate, WA Department of Health, Perth, WA.
  • 2 PathWest Laboratory Medicine WA, Perth, WA.
  • 3 Kimberley Public Health Unit, Broome, WA.


We thank Dr Carole Reeve (Public Health Medical Officer, Kimberley Public Health Unit, Broome), Dr Shelley Deeks (formerly, Deputy Director, Surveillance, National Centre for Immunisation Research and Surveillance), the staff of the Kimberley Population Health Unit, and laboratory staff at PathWest.

Competing interests:

None identified.

  • 1. National Health and Medical Research Council, Department of Health and Ageing. The Australian immunisation handbook. 9th ed. Canberra: Australian Government, 2008.
  • 2. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. 11th ed. Washington, DC: Public Health Foundation, 2009. (accessed Jul 2009, link updated Sep 2009).
  • 3. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet 2008; 371: 932-944.
  • 4. Aratchige P, McIntyre P, Quinn H, Gilbert G. Recent increases in mumps incidence in Australia: the “forgotten” age group in the 1998 Measles Control Campaign. Med J Aust 2008; 189: 434-437. <MJA full text>
  • 5. Codde DJ. Rates calculator. Version 9.3.1. Perth: Epidemiology and Geographic Information System Branch, Department of Health Western Australia, 2007.
  • 6. Coleman K, Markey P, Krause V. Mumps in the NT. NT Dis Control Bull 2008; 15 (4): 11-17. December 2008.pdf (accessed Jul 2009).
  • 7. Medicare Australia. Australian Childhood Immunisation Register (ACIR) statistics. (accessed Jul 2009).
  • 8. Sheehan J. An information system for rural community services. In: Chater B, Malko K, editors. A fair go for rural health — forward together. Proceedings of the 2nd National Rural Health Conference; 1993 Feb 12–14; Armidale, NSW.
  • 9. Gail M, Benichou J. Encyclopedia of epidemiologic methods. Chichester, UK: John Wiley, 2000.
  • 10. Dayan G, Quinslink P, Parker A, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358: 1580-1589.
  • 11. Public Health Agency of Canada. Information for health professionals. Mumps in Canada, 2007. (accessed Jul 2009).
  • 12. Bernard H, Schwarz N, Melnic A, et al. Mumps outbreak ongoing since October 2007 in the Republic of Moldova. Euro Surveill 2008; 13 (13). pii: 8079.
  • 13. Boxall N, Kubinyiova M, Prikazsky V, et al. An increase in the number of mumps cases in the Czech Republic, 2005-2006. Euro Surveill 2008; 13 (16). pii: 18842.
  • 14. Park D, Nam M, Kim J, et al. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 2007; 25: 4665-4670.
  • 15. Savage E, Ramsay M, White J, et al. Mumps outbreaks across England and Wales in 2004: observational study. BMJ 2005; 330: 1119-1120.
  • 16. Gee S, O’Flanagan D, Fitzgerald M, Cotter S. Mumps in Ireland, 2004–2008. Euro Surveill 2008; 13 (18). pii: 18857.
  • 17. Karagiannis I, van Lier A, van Binnendijk R, et al. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill 2008; 13 (24). pii: 18901.
  • 18. Fine P, Zell E. Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. Am J Epidemiol 1994; 139: 77-90.
  • 19. Anderson R, May R. Vaccination and herd immunity to infectious diseases. Nature 1985; 318: 323-329.
  • 20. Schaffzin J, Pollock L, Schulte C, et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics 2007; 120: e862-e868.
  • 21. Harling R, White J, Ramsay M, et al. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005; 23: 4070-4074.
  • 22. Savage E, Brown D, Ramsay M. Mumps epidemic: United Kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep 2006; 55: 173-175.
  • 23. Senanayake S. Mumps: a resurgent disease with protean manifestations. Med J Aust 2008; 189: 456-459. <MJA full text>
  • 24. McIntyre P, Menzies R. Immunisation: reducing health inequality for Indigenous Australians [editorial]. Med J Aust 2005; 182: 207-208. <MJA full text>
  • 25. Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 2003 to 2006. Commun Dis Intell 2008; 32 Suppl: 2-67.
  • 26. National Advisory Committee on Immunization. Statement on mumps vaccine. An Advisory Committee Statement. Can Commun Dis Rep 2007; 33: 1-10. (accessed Feb 2009).
  • 27. Gidding H, Burgess M, Kempe A. A short history of vaccination in Australia. Med J Aust 2001; 174: 37-40.
  • 28. Rubin S, Mauldin J, Chumakov K, et al. Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains. Vaccine 2006; 24: 2662-2668.
  • 29. Nöjd J, Tecle T, Samuelsson A, Orvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001; 19: 1727-1731.
  • 30. Jin L, Rima B, Brown D, et al. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol 2005; 150: 1903-1909.
  • 31. Inou Y, Nakayama T, Yoshida N, et al. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol 2004; 73: 97-104.
  • 32. Jin L, Brown D, Litton P. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis 2004; 189: 1001-1008.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.